Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Decrease in uptake of SARS-CoV-2 vaccine in patients with inflammatory bowel disease on intravenous biological therapy.

Journal article

Selim R. et al, (2022), The lancet. Gastroenterology & hepatology

Determinants of uptake of a third dose of SARS-CoV-2 vaccines in patients with inflammatory bowel disease.

Journal article

Wellens J. et al, (2022), The lancet. Gastroenterology & hepatology

Anti–SARS-CoV-2 Antibody Responses in Patients With IBD Treated With Biologics: Are We Finding CLARITY?

Journal article

Chapman TP. et al, (2021), Gastroenterology, 161, 2057 - 2059

Systemic Inflammation in Preclinical Ulcerative Colitis.

Journal article

Bergemalm D. et al, (2021), Gastroenterology, 161, 1526 - 1539.e9

SARS-CoV-2 vaccination uptake by patients with inflammatory bowel disease on biological therapy.

Journal article

Selim R. et al, (2021), The lancet. Gastroenterology & hepatology

SARS-CoV-2 Vaccination in IBD: Past Lessons, Current Evidence, and Future Challenges.

Journal article

Wellens J. et al, (2021), Journal of Crohn's & colitis, 15, 1376 - 1386

Predicting Outcome in Acute Severe Colitis-Controversies in Clinical Practice in 2021.

Journal article

Gupta V. et al, (2021), Journal of Crohn's & colitis, 15, 1211 - 1221

Reply

Journal article

Nowak JK. et al, (2021), Gastroenterology, 160, 2622 - 2623

Load More